GLADIUS PHARMACEUTICALS
Our website is being revised and will be available soon
Gladius Pharmaceuticals is a privately-owned company developing novel antibiotics for the treatment of life-threatening infections caused by multi-drug resistant bacteria
 
 
 
 
 
 
 
 MICHAEL ATKIN, President and Chief Executive Officer
LARRY SUTTON, MD PhD, Scientific Founder
DOMENIC DE LUCA, Chief Financial Officer

MAIN INVESTORS
Merck Lumira Biosciences Fund, L.P.
S.R. One, Limited
Fonds de solidarité FTQ

ADDRESS
3575 Avenue du Parc, Suite 4310
Montréal, Québec, H2X 3P9
Canada

CONTACT
Phone: 514.312.9002
Email: info@gladiuspharma.com